OCA at 08:05, 22 May 2024

2024-05-22T08:05:22Z

←Older revision		Revision as of 08:05, 22 May 2024
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 8sq8 is ~~ON HOLD~~	+	==X-ray crystal structure of Acinetobacter baumanii beta-lactamase variant OXA-109 in complex with doripenem==
		+	<StructureSection load='8sq8' size='340' side='right'caption='[[8sq8]], [[Resolution\|resolution]] 2.27Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[8sq8]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Acinetobacter_baumannii Acinetobacter baumannii]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8SQ8 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8SQ8 FirstGlance]. <br>
		+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.27Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=4J6:(4R,5S)-5-[(2S,3R)-3-HYDROXY-1-OXOBUTAN-2-YL]-4-METHYL-3-({(3S,5S)-5-[(SULFAMOYLAMINO)METHYL]PYRROLIDIN-3-YL}SULFANYL)-4,5-DIHYDRO-1H-PYRROLE-2-CARBOXYLIC+ACID'>4J6</scene>, <scene name='pdbligand=BCT:BICARBONATE+ION'>BCT</scene>, <scene name='pdbligand=KCX:LYSINE+NZ-CARBOXYLIC+ACID'>KCX</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8sq8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8sq8 OCA], [https://pdbe.org/8sq8 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8sq8 RCSB], [https://www.ebi.ac.uk/pdbsum/8sq8 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8sq8 ProSAT]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/A8JZR7_ACIBA A8JZR7_ACIBA]
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	OXA-66 is a member of the OXA-51 subfamily of class D beta-lactamases native to the Acinetobacter genus that includes Acinetobacter baumannii, one of the ESKAPE pathogens and a major cause of drug-resistant nosocomial infections. Although both wild type OXA-66 and OXA-51 have low catalytic activity, they are ubiquitous in the Acinetobacter genomes. OXA-51 is also remarkably thermostable. In addition, newly emerging, single and double amino acid variants show increased activity against carbapenems, indicating that the OXA-51 subfamily is growing and gaining clinical significance. In this study, we used molecular dynamics simulations, X-ray crystallography, and thermal denaturation data to examine and compare the dynamics of OXA-66 wt and its gain-of-function variants: I129L (OXA-83), L167V (OXA-82), P130Q (OXA-109), P130A, and W222L (OXA-234). Our data indicate that OXA-66 wt also has a high melting temperature, and its remarkable stability is due to an extensive and rigid hydrophobic bridge formed by a number of residues around the active site and harbored by the three loops, P, Omega, and beta5-beta6. Compared to the WT enzyme, the mutants exhibit higher flexibility only in the loop regions, and are more stable than other robust carbapenemases, such as OXA-23 and OXA-24/40. All the mutants show increased rotational flexibility of residues I129 and W222, which allows carbapenems to bind. Overall, our data support the hypothesis that structural features in OXA-51 and OXA-66 promote evolution of multiple highly stable variants with increased clinical relevance in A. baumannii.

-	~~Authors~~:	+	Structural and Dynamic Features of Acinetobacter baumannii OXA-66 beta-Lactamase Explain Its Stability and Evolution of Novel Variants.,Klamer ZL, June CM, Wawrzak Z, Taracila MA, Grey JA, Benn AMI, Russell CP, Bonomo RA, Powers RA, Leonard DA, Szarecka A J Mol Biol. 2024 May 8;436(12):168603. doi: 10.1016/j.jmb.2024.168603. PMID:38729259<ref>PMID:38729259</ref>

-	~~Description~~:	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased~~ Structures]]	+	</div>
		+	<div class="pdbe-citations 8sq8" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Acinetobacter baumannii]]
		+	[[Category: Large Structures]]
		+	[[Category: June CM]]
		+	[[Category: Leonard DA]]
		+	[[Category: Powers RA]]
		+	[[Category: Szarecka A]]
		+	[[Category: Wawrzak Z]]

OCA: Protected "8sq8" [edit=sysop:move=sysop]

2023-05-10T05:28:27Z

Protected "8sq8" [edit=sysop:move=sysop]

←Older revision

Revision as of 05:28, 10 May 2023

OCA: New page: '''Unreleased structure''' The entry 8sq8 is ON HOLD Authors: Description: Category: Unreleased Structures

2023-05-10T05:28:24Z

New page: '''Unreleased structure''' The entry 8sq8 is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 8sq8 is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]

8sq8 - Revision history

OCA at 08:05, 22 May 2024

OCA: Protected "8sq8" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 8sq8 is ON HOLD Authors: Description: Category: Unreleased Structures